Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S17 pseudogene 15 (RPS17P15) is a processed pseudogene found in the human genome. It is one of multiple pseudogene copies generated via retrotransposition of the parental ribosomal protein S17 (RPS17) gene. Unlike the functional RPS17 gene, which encodes a component of the 40S ribosomal subunit essential for protein synthesis, RPS17P15 does not code for a functional protein. Pseudogenes like RPS17P15 generally do not produce active proteins and have no known biological or disease-associated function. There is no evidence to suggest that RPS17P15 is involved in disease, acts as a drug target, or is used as a biomarker. The parent gene RPS17, but not its pseudogenes, is associated with disorders like Diamond-Blackfan anemia. RPS17P15 is a pseudogene—not a receptor, enzyme, transporter, or any other classical therapeutic target, and it has no known functional role or relevance as a drug or biomarker target in clinical or research settings.
Not a target for therapeutic intervention; no mechanism of action applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S17 pseudogene 15 (RPS17P15).